Global perspectives on vaccine financing.
Despite the great promise of immunization and recent progress in immunizing children throughout the developing world, a global crisis in vaccine R&D, supply and delivery is faced. This article reviews how the global US6 billion dollars vaccine market is structured and its attractiveness to vaccine suppliers, the international two-tiered pricing system in which high-income countries generate about 82% of vaccine revenues but represent only 12% of the doses, the impact of schedule divergence as high-income and developing countries introduce different vaccines, the role of the US government, and possible approaches to ameliorate the crisis.
University of Colorado School of Medicine and The Childrens Hospital, 1056 E. 19th Ave., B032, Denver, CO 80218, USA. berman.stephen@tchden.org
Stephen
S
Berman
Robert B
RB
Giffin
D019049:Developed Countries; D003906:Developing Countries; D015195:Drug Design; D004345:Drug Industry / Q000191:economics; D005380:Financing, Government; D014943:Global Health; D017048:Health Care Costs; D006801:Humans; D017589:Immunization Programs / Q000191:economics*; D012109:Research Support as Topic; D014481:United States; D014612:Vaccines / Q000191:economics* / Q000600:supply & distribution
D014612:Vaccines